Mirion Technologies/$MIR
1D1W1MYTD1Y5YMAX
Capital at risk
About Mirion Technologies
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.
- Ticker
- $MIR
- Sector
- Digital Hardware
- Primary listing
- NYSE
- Employees
- 3,281
- Headquarters
- Atlanta, United States
- Website
- www.mirion.com
MIR Metrics
BasicAdvanced
$3.8B
177.26
$0.09
1.06
-
Price and volume
Market cap
$3.8B
Beta
1.06
52-week high
$30.28
52-week low
$14.11
Average daily volume
3.5M
Financial strength
Current ratio
3.198
Quick ratio
2.436
Long term debt to equity
0.653
Total debt to equity
0.658
Interest coverage (TTM)
2.06%
Profitability
EBITDA (TTM)
219.9
Gross margin (TTM)
48.05%
Net profit margin (TTM)
2.39%
Operating margin (TTM)
6.81%
Effective tax rate (TTM)
15.79%
Revenue per employee (TTM)
$310,000
Management effectiveness
Return on assets (TTM)
1.43%
Return on equity (TTM)
1.51%
Valuation
Price to earnings (TTM)
177.26
Price to revenue (TTM)
3.663
Price to book
2.09
Price to tangible book (TTM)
-6.56
Price to free cash flow (TTM)
28.081
Free cash flow yield (TTM)
3.56%
Free cash flow per share (TTM)
0.558
Growth
Revenue change (TTM)
15.68%
Earnings per share change (TTM)
91.99%
3-year revenue growth (CAGR)
10.57%
3-year earnings per share growth (CAGR)
-60.57%
What the Analysts think about MIR
Analyst ratings (Buy, Hold, Sell) for Mirion Technologies stock.
Analyst projections of the future price of Mirion Technologies stock.
Bulls say / Bears say
Mirion reaffirmed its full-year 2026 guidance, targeting 22.0%–24.0% revenue growth and $285–$300 million of adjusted EBITDA, signaling strong management confidence in sustained demand. (Business Wire(ir.mirion.com))
Second-quarter revenue increased 19.7% to $266.8 million, driven by robust demand across both Nuclear & Safety and Medical segments. (Business Wire(ir.mirion.com))
Q2 orders excluding the Paragon and Certrec acquisitions rose 10% year-on-year to $229 million, reflecting strong backlog growth fuelled by nuclear power market momentum. (Business Wire(ir.mirion.com))
GAAP net income declined 4.7% year-on-year in Q2 to $8.1 million and GAAP EPS fell to $0.03 from $0.04, indicating pressure on profitability despite revenue growth. (Business Wire(ir.mirion.com))
Mirion recorded a GAAP net loss of $3.4 million in Q1 and saw its adjusted EBITDA margin contract to 21.1% from 23.1% a year ago, highlighting first-half profitability challenges. (SEC 8-K(ir.mirion.com))
The balance sheet shows significant leverage, with $443.7 million of non-current debt and $756.6 million of convertible debt as of June 30, 2026, alongside $42.2 million of interest expense in FY 2025, raising financial risk. (Business Wire Q2(ir.mirion.com))
Data summarised monthly by Lightyear AI. Last updated on 3 Sept 2026.
MIR Financial Performance
Revenues and expenses
MIR Earnings Performance
Company profitability
Upcoming events
No upcoming events
MIR News
AllArticlesVideos
Funds containing MIR
AllEURUSDGBP
Fund name | Fund size | $MIR weighting |
|---|---|---|
iShares Digital Security€L0CK | €1.7B | 0.70% |
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.22% |
iShares S&P Small Cap 600£ISP6 | £2.4B | 0.22% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.12% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.08% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.